PGY5 Holman-Pathway RadOnc Resident, Cancer Biology PhD Candidate @UM_JMH_Radonc. Former T32 Research Fellow @UmiamiMedicine @SylvesterCancer
Joined August 2021
- Tweets288
- Following340
- Followers248
- Likes1.3K
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Starting the day with an excellent breast planning lecture from @MonaArbabMD as part of our junior attending guest lecturing series! If you are a junior attending and like to teach reach out to me we want your teaching wisdom! 🙌
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Thankful to St Jude Children Research Hospital and @ASTRO_org #ASTRO26 for allowing me to present Phase IV SJPROTON1 study on MSK adverse events on Pencil Beam Proton Therapy in #Pediatrics #RadOnc #IMG @ProjectImg. Dr John Lucas one of the most brilliant minds and humble human being
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Our ⭐️ trainees are presenting their exciting lung cancer research at #ASTRO26!
Eight presentations, with four receiving special recognition 🏆 - a reflection of their hard work, dedication, and outstanding science.
Come by, support our rising stars, and learn about some exciting new work in lung cancer! 🫁🔬
@ASTRO_org @MoffittNews @MoffittRadOnc @KoreanASTRO #JKimLab #MoffittASTRO26
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Get to know UT MD Anderson's Chief Scientific Officer, Dr. Albert Koong.
He shares what led him to UT MD Anderson, about his lab's investigations into the tumor microenvironment and what excites him about the future of research: spr.ly/6001BG9U7l @ACKoongMDPhD #EndCancer
Absolute Rockstar!!!
Hi everyone! Excited to share that I’m applying into #RadOnc for #Match2027 ☢️
I’m Raksha Narasimhan, an MD/ MPH student at @umiamimedicine with research interests in breast & gynecologic cancers and survivorship. Very grateful and excited for the cycle ahead!
AAMC ID: 15261755
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Hi everyone! Excited to share that I’m applying into #RadOnc for #Match2027 ☢️
I’m Raksha Narasimhan, an MD/ MPH student at @umiamimedicine with research interests in breast & gynecologic cancers and survivorship. Very grateful and excited for the cycle ahead!
AAMC ID: 15261755
RT @nbn426: 👋👋 prospective residents : Please join us on 09/17 for a meet and greet with myself and our residents to learn about our excel…
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Congratulations to Dean @HenriFordMD on his induction into the American Philosophical Society, one of the nation's most selective intellectual honors. 👏
Founded by Benjamin Franklin in 1743, the society recognizes individuals whose work has made an extraordinary impact on knowledge and public life. Dean Ford joins its distinguished membership in recognition of his pioneering pediatric surgery research, leadership in academic medicine, mentorship of physician-scientists and longstanding commitment to global health.
Read more: loom.ly/F-Euvnc
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
For children facing cancer and other serious illnesses, recovery includes getting back to school and thriving. 📚
A new PCORI-funded study led by Sylvester’s Dr. Raymond Mailhot (@raymailhotvega) aims to make school success a meaningful measure of children’s health and outcomes. spr.ly/6011B1LdOv
RT @nbn426: Had a great radonc resident retreat day @SylvesterCancer - we did exercises discussing stress management, wellness techniques,…
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Truly thankful to @EGFRResisters and @jillfeldman4 for the opportunity to be part of the EGFR Resisters Patient & Caregiver Summit in Chicago and for their continued leadership in patient advocacy and education. 💙
I shared our #ASCO26 work on AI in EGFR-mutant NSCLC, conducted in collaboration with @Larvol 🤖, along with practical ways patients can use AI to better understand medical information, explore clinical trials, compare treatment options, translate information, and prepare questions for clinic visits.
We also discussed the limitations of AI- and why it should support, not replace, conversations with the oncology team.
#EGFR #PatientAdvocacy #AI #NSCLC
@SylvesterCancer @GlopesMd @Latinamd @lcrf_org @LUNGevity @HemOncMiami @Cornerstone_CME @cancerGRACE
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Proud to share that Sylvester CCC/Radiation Oncology is now the #1 accruing main member in NRG Oncology clinical trials worldwide! Huge credit to our incredible team and the patients who make this research possible!🏆
@umiamimedicine
@UMiamiHealth
@SylvesterCancer
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Extremely grateful to have been named a recipient of the 2026 ASTRO-BCRF Trainee Travel Award! Very excited for the opportunity to attend #ASTRO2026 this fall 🚀
ASTRO and the Breast Cancer Research Foundation (BCRF) are pleased to announce the 10 recipients of the 2026 ASTRO-BCRF Trainee Travel Awards.
By providing financial support to attend #ASTRO26, these awards help emerging leaders in radiation oncology access valuable educational opportunities, connect with mentors and peers, and advance their professional development.
Meet this year's recipients: ow.ly/QUZZ50ZsmaB
@BCRFcure @OrionH2201 @afuaodarko @Kolade__Olabode
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Delighted that our University of Miami Radiation Oncology Residency Program made an extraordinary leap in national standings, rising from #40 in 2025 to #16 in 2026.
Grateful for our Vice Chair and outgoing PD @BrandonMahal and our new PD Neil Newman (@nbn426 )! @UMiamiHealth
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Absolute best part of the year - orienting our four new Rad Onc residents @SylvesterCancer - can’t wait to see what you all accomplish 🙌☺️
@BrandonMahal
Congratulations 🎉 Outstanding work @d_bayik
📣Super excited that the first manuscript from our lab @umiamimedicine @SylvesterCancer published today @NatureCancer 🙌 (1/5)
nature.com/articles/s43018-0…
Excited to join the 2026–2027 SNO Editorial Fellowship Program. Grateful for this opportunity and thankful to @drbredel for his mentorship and sponsorship. Looking forward to learning, contributing, and growing within the neuro-oncology community. @NeuroOnc @SylvesterCancer
Ifeanyichukwu Ogobuiro, MD, MHS retweeted
Brandon Emanuel León, a third-year Ph.D. student, is researching glioblastoma, one of the deadliest and most aggressive forms of brain cancer. In his search for a treatment, León is repurposing FDA-approved drugs originally designed for other diseases. Learn about his work: loom.ly/7MmCvTI
